The chimeric oncoprotein E2a-Pbx1 results from fusion of the E2A and PBX1 genes following t(1;19) chromosomal translocations in B cell precursor acute leukemias. Experimentally B cell progenitors do not tolerate constitutive expression of E2a-Pbx1 which contrasts with transformation of several other cell types following its stable expression both in vitro and in vivo.
Introduction
Chromosomal translocations constitute an important mechanism by which cellular proto-oncogenes are converted to oncogenes in human cancers. Several chromosomal translocations in leukemias lead to production of fusion proteins with features of chimeric transcription factors (Cleary, 1991) . The ®rst of these was reported in pre B cell acute leukemias, where the t(1;19) translocation results in expression of chimeric oncoprotein E2a-Pbx1 (Kamps et al., 1990; Nourse et al., 1990) . One of the genes involved in this translocation, E2A, codes for two alternatively spliced transcription factors, E12 and E47, which regulate developmental pathways in muscle, pancreatic and B cells (Kadesch, 1992) . The other gene, PBX1, codes for a highly conserved member of a small subfamily of divergent homedomain-containing proteins with unique genetic and biochemical properties (Monica et al., 1991) . The Drosophila homolog of Pbx1, exd, has been shown genetically to act in parallel with Hox proteins in the determination of segmental identity (Rauskolb et al., 1993) . A similar role for Pbx proteins is suggested by their potential involvement in a highly conserved autoregulatory loop that controls HoxB1 expression in the mouse hindbrain (Popperl et al., 1995) . Recent biochemical studies support a role for Pbx/exd proteins as DNA-binding cofactors for Hox proteins (reviewed in Mann and Chan, 1996) and suggest that the binding activities of Pbx-Hox complexes contribute to the position-speci®c activities of Hox genes (Chang et al., 1996) .
The transcriptional properties of Pbx1 are altered following fusion with E2a due to the acquisition of two transcriptional activation domains located within the E2a moiety (Aronheim et al., 1993; Quong et al., 1993) . E2a-Pbx1 is a potent activator, whereas Pbx1 is a nonactivator, of synthetic reporter genes containing Pbx/ Hox consensus binding sites Lu et al., 1994; Van Dijk et al., 1993) . Due to loss of the E2a basic DNA-binding region but retention of the Pbx homeodomain, the E2a-Pbx1 chimera displays DNAbinding properties identical to those of wild type Pbx proteins and in this capacity binds DNA cooperatively with class I Hox proteins (Chang et al., 1995 (Chang et al., , 1996 Lu et al., 1995; Phelan et al., 1995) . These features support an hypothesis that the oncogenic properties of E2a-Pbx1 result from subversion of target genes whose expression is normally regulated by wild type Pbx proteins in the context of their role as cofactors for Hox and non-Hox homeodomain proteins.
E2a-Pbx1 displays oncogenic activity in several dierent cell types despite its restricted association with a subset of human leukemias. Fibroblasts, myeloblasts and lymphoblasts have all been shown experimentally to undergo neoplastic change in response to forced expression of E2a-Pbx1 (Dedera et al., 1993; Kamps et al., 1991 Kamps et al., , 1993 Kamps et al., , 1996 Monica et al., 1994) . However, B cell precursors, the cell type involved in human t(1;19) leukemias, are curiously resistant to experimental transformation. In fact, precursor B cells in vitro do not tolerate stable expression of E2a-Pbx1 (unpublished observations). In vivo, expression of an E2a-Pbx1 transgene in the lymphoid compartment of transgenic mice resulted in profound hypoplasias, in contrast to the hyperplasias seen with other oncogenes expressed under similar conditions. In spite of this, E2a-Pbx1 mice developed T lineage, but not B lineage, lymphoblastic lymphomas although thymuses were noted to contain markedly increased numbers of cells undergoing apoptosis. These observations suggested that E2a-Pbx1 may modulate cell survival and that its oncogenic properties may depend on the relative resistance of various cell types of apoptosis.
Apoptosis, or programmed cell death, is a genetically controlled process (Ellis et al., 1991) that is frequently subject to failure in neoplastic cells. This has been most dramatically illustrated by studies of Bcl-2 and related family members (reviewed in Nunez and Clarke, 1994 ) which function as repressors or inducers of programmed cell death. The inter-relationships of growth control and apoptotic pathways are further demonstrated by studies showing that tumor suppressor protein p53 induces programmed cell death following DNA damage by ionizing radiation (Kastan et al., 1991) or certain genotoxic chemicals (Lowe et al., 1993) . The role of p53 in apoptosis is independent of its ability to potentiate cell cycle arrest through induction of p21 (Wagner et al., 1994) . Recent reports show a functional role for p53 in oncogene-mediated apoptosis (Harrington et al., 1994) . Overexpression of the proto-oncogene c-myc has been shown to modulate apoptotic cell death in rat ®broblasts under low serum conditions or drug-induced cell cycle arrest (Evan et al., 1992) . Myc-induced apoptosis is dependent on p53 induction (Hermeking and Eick, 1994) and may represent a cell-suicide response to inappropriate cell cycle progression. Likewise the adenoviral oncoprotein E1A induces cell cycle advancement and concomitant p53-mediated apoptosis in primary rodent cells but coexpressed E1B inhibits p53 with resultant suppression of apoptosis (Debbas and White, 1993) .
In this report we show that conditional expression of the nuclear oncoprotein E2a-Pbx1 induces apoptosis in hematopoietic precursor cell lines in vitro. A structurefunction analysis demonstrated that induction of apoptosis by E2a-Pbx1 requires its function as a chimeric transcription factor. E2a-Pbx1-induced apoptosis proceeds through a BCL2-responsive checkpoint and eventuates in PARP inactivation but does not involve alterations of several other known mediators of apoptosis including p53. Furthermore, unlike myc, E2a-Pbx1 does not induce apoptosis or continued cycling activity of Rat-1 ®broblasts in low serum conditions. These data demonstrate that E2a-Pbx1 initiates programmed cell death in hematopoietic cells but it does so by a mechanism dierent from other nuclear oncoproteins that is not dependent on p53.
Results
Conditional expression of E2a-Pbx1 under control of a metal response element in the Reh B-cell precursor cell line
To obtain conditional expression of E2a-Pbx1 in B cell precursors, the E2a-Pbx splice variant 1b was cloned into the metal response element vector MREpNEO and the resulting construct (MRE-E2A-PBX1b) ( Figure 1a ) was transfected by electroporation into Reh cells. Stably transfected Reh cells were selected in G-418 and single cell clones were isolated by FACS sorting or limiting dilution. Cells (MT1) containing the empty MRE-pNEO vector were also selected and used as negative controls in all subsequent experiments.
Transfected Reh clones were screened for levels of E2a-Pbx1b expression in the absence or presence of ZnSO 4 . Several clones exhibited induced levels of E2a-Pbx1b equal to or greater than endogenous E2a proteins E12/E47 as detected by Western blot analysis. The results obtained from a representative clone (A2) are shown in Figure 1b . Following zinc exposure, E2a-Pbx1b was rapidly induced in the A2 clone as evidenced by its detection as early as 2 h posttreatment (data not shown). Maximal protein expression was observed between 8 ± 12 h post induction ( Figure 1b ) and these levels were maintained at all subsequent time points out to 60 h. Prior to induction, no E2a-Pbx1b was detected in A2 cells by sensitive Western blot analysis indicating minimal if any leakiness of the inducible MRE construct. The antibody employed for Western blot analysis also reacted with endogenous wild type E2a proteins whose levels remained relatively constant in both the MT1 and A2 clones throughout the induction period.
E2a-Pbx1b induces apoptosis of Reh cells
To assess the eects of enforced E2a-Pbx1b expression on precursor B cells, the MT1 and A2 clones of Reh were treated with two dierent concentrations of ZnSO 4 (25 or 100 mM) for 72 h. At speci®c time points postinduction, cell numbers and viabilities were scored by microscopic assessment of morphologic features characteristic of apoptosis (cytoplasmic blebbing and nuclear condensation). Prior to ZnSO 4 induction, over 95% of A2 cells were viable, but by 24 h post-induction with 100 mM ZnSO 4 , A2 viability dropped to 80% and continued to decrease to approximately 20% survival by 72 h (Figure 2a ). In contrast, treatment of the A2 clone with 25 mM ZnSO 4 did not appreciably alter overall cell survival from pretreatment levels demonstrating a dosage dependent response of A2 to zinc treatment. Neither concentration of ZnSO 4 induced cell death in Reh pre-B cell clones stably transfected with MRE-E2A-PBX1b (A2) or MRE vector without insert (MT1) were treated with 100 mM ZnSO 4 for the times listed above the gel lanes. Cell lysates were examined by Western blot to determine the kinetics of E2a-Pbx1b induction. E2a-Pbx1b was detected using an anti-E2a monoclonal antibody (Jacobs et al., 1993) which also recognizes the endogenous, wild type E2a proteins whose migrations are indicated to the right the MT1 control cells whose survival was maintained at greater than 90% throughout the 72 h treatment period.
The response of A2 cells to dierent concentrations of ZnSO 4 was directly related to the induced levels of E2a-Pbx1b protein expression as assessed by Western blot analysis. Considerably lower levels of E2a-Pbx1b were detected at 25 mM compared to the robust expression at 100 mM (Figure 2b ). Neither concentration had an appreciable eect on expression of endogenous E2a proteins in the MT1 and A2 clones.
Cell death induced by E2a-Pbx1b demonstrated molecular and morphologic features characteristic of apoptosis. Ethidium bromide-agarose gel electrophoresis of chromosomal DNA isolated 36 h post-induction with zinc showed oligonucleosomal DNA degradation in A2 but not MT1 cells (Figure 2c ). Bright ®eld microscopy of A2 cells showed numerous cells with condensed chromatin, severe vacuolization and membrane blebbing characteristic of cells undergoing apoptosis in vitro (Figure 2d ).
Induction of apoptosis by E2a-Pbx1 requires its function as a transcription factor
Previous studies have demonstrated that E2a-Pbx1 contains several domains that are necessary for its transcriptional and oncogenic properties (Chang et al., 1996; Monica et al., 1994) . To assess which portions of E2a-Pbx1 are required for induction of apoptosis, we performed a structure/function analysis that utilized several mutant forms of E2a-Pbx1 whose expression was regulated by the MRE in stably transfected Reh cells. The various constructs employed for these studies contained deletions in the Pbx portion of the chimeric protein as shown schematically in Figure 3a . We also assessed the properties of E2a-Pbx1a, an isomer which diers at its carboxy terminus due to dierential splicing (Nourse et al., 1990) . Furthermore, to assess the speci®c contribution of the Pbx moiety versus other DNAbinding motifs, we tested the apoptotic potential of E2a-Hlf, another leukemia-associated E2a chimera that contains a basic region and leucine zipper fused to E2a in place of the homeodomain protein Pbx1 found in E2a-Pbx1 (Hunger et al., 1992; Inaba et al., 1994) . Reh clones harboring the various mutant E2a-Pbx1 constructs and E2a-Hlf were tested for expression of the mutated proteins prior to and following zinc induction. Individual clones capable of inducing appropriately sized proteins at levels equal to or greater than endogenous E2a proteins by Western blot analysis ( Figure 3b ) were employed for further studies.
The apoptotic potentials of the various E2a chimeras were determined by morphologic assessments of cell survival after 72 h of induction with 100 mM ZnSO 4 ( Figure 3a ). Both isomers (a and b) of E2a-Pbx1 were capable of inducing apoptosis under these conditions although E2a-Pbx1b was slightly more potent than E2a-Pbx1a. A mutant (DPbx1) lacking all Pbx-derived sequences and consisting solely of the E2a portion of the chimera was incapable of inducing apoptosis indicating a need for speci®c motifs from Pbx1. The required Pbx sequences appeared to consist of more than its homeodomain since a mutant (HD 232 ± 298 ) containing the Pbx homeodomain fused directly to E2a was incapable of inducing apoptosis. However, inclusion of 12 additional amino acids¯anking the carboxy end of the homeodomain (construct HD 232 ± 310 ) restored apopototic properties to the chimera (50% of E2a-Pbx1b activity). These data de®ne a minimal portion of Pbx1 that is functionally competent for induction of apoptosis and are consistent with previous (Chang et al., 1995) . The required sequences¯anking the Pbx homeodomain have been proposed to mediate heterologous interactions with Hox proteins (Chang et al., 1996) . Two additional constructs (1bDHD and D232 ± 430) coding for mutants that lack the Pbx homeodomain were incapable of inducing apoptosis providing further evidence that the E2a-Pbx1 chimera needs to bind DNA through its homeodomain to induce apoptosis under these experimental conditions. A mutant (D299 ± 308) with partial deletion of the Hox cooperativity motif (Chang et al., 1997) was severely compromised in its apoptotic properties but still able to adversely aect viability (45% of E2a-Pbx1b activity). No apoptosis was observed following induction of E2a-Hlf expression suggesting that speci®c recognition of Pbx but not Hlf targets renders Reh cells susceptible to apoptosis.
Eects of E2a-Pbx1 on known modulators of apoptosis
To investigate potential mechanisms by which E2a-Pbx1 induces apoptosis, we assessed the expression patterns of various proteins known to be modulators of apoptosis using Western blot analysis following 100 mM zinc induction of A2 and MT1 cells. Immunodetection of Bcl-2, a known repressor of programmed cell death, showed that its levels decreased in A2 but not MT1 cells (Figure 4 ), however this decrease occurred late after 48 h of induction suggesting that it was not a primary cause of apoptosis in A2 cells. We also assessed the expression levels of Bcl-2 superfamily members Mcl-1, a repressor of cell death, and Bax, a death promoter, by Western blot using immune sera speci®c for these proteins. Both were unaected over the 60 h period during which A2 cells were undergoing E2a-Pbx1-induced apoptosis (Figure 4) . We also quantitated the levels of tumor suppressor gene product p53 given its previously reported role in programmed cell death induced by nuclear oncoproteins adenovirus E1a and Myc (Debbas and White, 1993; Hermeking and Eick, 1994) . The levels of p53 protein were found to increase dramatically in A2 cells undergoing E2a-Pbx1-induced apoptosis, however, a comparable increase of p53 was observed in MT1 cells (Figure 4 ) which lack E2a-Pbx1 and do not undergo apoptosis suggesting that p53 levels were responding to the zinc treatment alone although no apparent eects on the cycling activity of MT1 cells were observed (data not shown).
Finally, we determined whether PARP expression and composition were aected by induction of apoptosis by E2a-Pbx1b. PARP has been shown to play a role as a distal downstream mediator in Figure 3 Structural requirements of E2a-Pbx1 for induction of apoptosis. (a) Schematic illustrations are shown of the various intact and mutant E2a-Pbx1 proteins expressed under control of the MRE in Reh cells. Deleted regions of mutant constructs are depicted by blanks. Also shown is the chimeric bZIP protein E2a-Hlf. Cross-hatched boxes denote the Pbx1 homeodomain or Hlf bZIP motifs. Results of apoptosis assays for each construct are expressed as a percentage of apoptotic activity relative to intact E2a-Pbx1b. The percentage of surviving cells was assessed over 72 h following addition of ZnSO 4 (100 mM ®nal concentration) to the culture media. Viable cell numbers at each time point were determined by light microscopic assessment of morphological changes characteristic of apoptosis. Each value represents the mean of triplicate samplings from duplicate experiments. (b) Clonal populations of Reh cells stably transfected with intact or mutant E2a-Pbx1 constructs under control of an MRE were induced with 100 mM ZnSO 4 for 12 h and cell lysates from each were used for Western blot analysis using an anti-E2a monoclonal antibody. The M r of each was assessed using prestained protein standards Figure 4 Eects of E2a-Pbx1b on known modulators of apoptosis. Cells from Reh clones MT1 and A2 were exposed to ZnSO 4 for time periods indicated above the gel lanes. Aliquots were examined by Western blot analysis using antibodies speci®c for various modulators or eectors of apoptosis as indicated to the right of the panels. Immunological reagents for the detection of Bcl-2, Bax, Mcl-1, p53 and PARP are described in Materials and methods. The total cellular protein loaded per gel lane was equalized based on OD 280 determinations. Molecular weights were calculated based on co-electrophoresis of standard size apoptosis, namely inactivation of PARP by proteolytic cleavage precedes chromatin degradation (Kaufmann et al., 1993) . Using an anti-PARP monoclonal antibody we observed cleavage of PARP from a native molecular weight of 116 kD to 85 kD over the 60 h timecourse (Figure 4) . In A2 cells, PARP cleavage was ®rst detected at 36 h post-induction with almost complete cleavage to the 85 kD form by 60 h. In contrast, the levels and size of PARP remained essentially unaltered in control MT1 cells following identical treatment with zinc. These data indicate that apoptosis induced by E2a-Pbx1 traverse a molecular pathway involving activation of a CED-3/ICE family protease which responds by proteolytically cleaving PARP.
Bcl-2 protects against E2a-Pbx1-induced apoptosis Given the known role of Bcl-2 in modulating the survival of progenitor B cells, the delayed reduction in Bcl-2 levels following enforced expression of E2a-Pbx1 in Reh cells suggested that Bcl-2 loss may partially contribute to the observed cell death. To further investigate the eects of Bcl-2 on E2a-Pbx1-induced apoptosis, Bcl-2 was constitutively expressed at high levels under control of the CMV promoter in MT1 and A2 cells. The resulting MT1-BCL2 and A2-BCL2 cells were then treated with zinc and assessed for apoptosis. A2-BCL2 cells were signi®cantly protected from cell death induced by E2a-Pbx1, displaying 80% survival at 72 h post-induction compared to 20% survival of A2 cells ( Figure 5 ). MT1-BCL2 cells showed slightly enhanced survival compared to MT1 in the presence of zinc. Thus, although A2 cells express detectable levels of endogenous Bcl-2, hyperexpression of exogenous Bcl-2 confers enhanced survival following enforced expression of E2a-Pbx1 perhaps by further neutralizing Bax, which is also expressed in Reh cells (Figure 4) . Our studies indicate that the apoptotic signals initiated by E2a-Pbx1 proceed through a checkpoint that is responsive to Bcl-2 and suggest a mechanism by which lymphoid cells expressing E2a-Pbx1 following chromosomal translocations may escape its apoptotic properties and contribute to leukemic development.
E2a-Pbx1-induced apoptosis does not require p53
An essential role has been demonstrated for p53 in mediating apoptosis induced by nuclear oncoproteins Myc and E1A. Our studies described above of apoptosis induced by E2a-Pbx1 in the A2 clone of Reh cells showed that p53 expression is markedly increased following E2a-Pbx1 expression, but a similar increase in p53 protein levels was observed in MT1 cells which do not express E2a-Pbx1, therefore a speci®c role for p53 could not be established. To further investigate a possible role for p53, we assessed the ability of E2a-Pbx1 to induce apoptosis in HL60 cells which lack functional p53 (Wolf and Rotter, 1985) . HL60 cells were stably transfected with MRE or MRE-E2A-PBX1b constructs, cloned and then used in quantitative apoptosis assays. Following induction of E2a-Pbx1b expression, survival of HL60-E2A-PBX1 cells decreased to approximately 40% at 72 h compared to greater than 90% survival for HL60- MRE cells (Figure 6 ). These data show that myeloid precursor cells as well as cells of the lymphoid lineage are susceptible to the apoptotic eects of E2a-Pbx1 and that p53 is not required for apoptosis to occur under these experimental conditions.
Constitutive expression of E2a-Pbx1 does not induce apoptosis or continued cycling of Rat-1 ®broblasts Since several nuclear oncoproteins render cells susceptible to apoptosis (e.g. E1A, Myc and E2F) by inducing cell cycle progression (Debbas and White, 1993; Hermeking and Eick, 1994; Shan and Lee, 1994) , we investigated whether E2a-Pbx1 may share similar properties. These studies were conducted in Rat-1 ®broblasts since Reh cells did not tolerate arrest and concurrent treatment with ZnSO 4 Rat-1 ®broblasts, unlike Reh, support constitutive expression of E2a-Pbx1 without undergoing apoptosis (Figure 7 ). Stably transfected, cloned Rat-1 cells expressing E2a-Pbx1, cmyc, or containing vector alone were grown to logarithmic phase and transferred to 0.1% FCS. The c-myc-expressing cells began undergoing apoptosis within hours of serum starvation. In contrast, Rat-1/ E2a-Pbx1 showed only background levels of apoptosis comparable to the control cells (data not shown). After serum starvation for 72 h, Rat-1/myc and Rat-1/E2a-Pbx1 cells were analysed for total DNA content by FACS. Rat-1/myc cells remained in cycle (17.8% S phase cells) similar to Rat-1/vector cells growing in 10% FCS (21.2% S phase). In contrast, Rat-1/E2a-Pbx1 and Rat-1/vector cells in 0.1% FCS showed considerably smaller S phase fractions (5.4% and 8.7%, respectively) consistent with growth arrest (Figure 7a) . Apoptosis of Rat-1/myc cells was evident by the large fraction containing sub-G1 DNA content. The percentage of cells actively traversing S phase was quantitated by metabolic labeling with 100 mM BrdU (Table 1) . Rat-1/myc cells incubated in 0.1% serum displayed an S phase fraction (30.0%) comparable to Rat-1/vector cells in 10% serum (28.6%). By comparison, Rat-1/E2a-Pbx1 and Rat-1/vector cells incubated in 0.1% serum displayed S phase fractions of 13.9% and 8.6%, respectively. Therefore, under low-serum conditions in which constitutive myc expression induces cell cycling and concomitant apoptosis of Rat-1 ®broblasts, no comparable eects are evident from forced expression of E2a-Pbx1. These data provide additional evidence that the oncoproteins E2a-Pbx1 and c-myc dier in the mechanisms by which they render cells susceptible to apoptosis.
Discussion
In this report we show that chimeric oncoprotein E2a-Pbx1 induces apoptosis of hematopoietic precursor cell lines in vitro and provide evidence that it initiates this process by a mechanism that diers from other nuclear oncoproteins. To demonstrate these phenomena, we employed a conditional expression system because previous attempts to constitutively express E2a-Pbx1 in lymphoid cell lines were unsuccessful. The levels of induced E2a-Pbx1 expression achieved in our experiments approximated steady-state levels of wild type E2a proteins in B lineage precursor cell lines. These levels are also comparable to those of E2a-Pbx1 proteins expressed under control of the E2A promoter in t(1;19)-bearing leukemia cells. Therefore, the observed eects on cell survival are a biologic property of E2a-Pbx1 at intracellular concentrations characteristic of human disease states and not simply a Total cellular proteins from Rat-1/E2a-Pbx1 clones were resolved by SDS ± PAGE followed by Western blot analysis using an anti-E2a antibody. Clone #1 displayed high level constitutive expression of E2a-Pbx1b and was employed for DNA content studies consequence of massive experimental over-expression. These studies extend previous work on E2A-PBX1 transgenic mice which initially suggested that E2a-Pbx1 was capable of rendering thymocytes susceptible to apoptosis (Dedera et al., 1993) . Increased numbers of apoptotic cells were measured in thymuses of these mice. Profound lymphopenias of both T and B cells were observed prior to development of lymphoblastic malignancies, however the cellular basis for these eects were not established. Our current studies suggest that the observed lymphopenias in transgenic animals were a direct result of adverse eects in vivo by E2a-Pbx1 on the survival of lymphoid progenitors comparable to those we found in vitro. We conclude that E2a-Pbx1 has the capability to modulate both the survival and neoplastic properties of lymphoid progenitors.
Mutational analyses indicated that E2a-Pbx1 requires its activity as a transcription factor to promote apoptosis. Deletion of all Pbx-derived sequences from E2a-Pbx1 eliminated its apoptotic activity indicating that cell death was not induced by possible dominantnegative eects of E2a lacking its carboxy-terminal bHLH DNA-binding and dimerization motifs. This possibility was raised by previous observations that the amino-terminal portion of E2a lacking its bHLH motifs has growth inhibitory properties in ®broblasts (Peverali et al., 1994) , however our studies exclude this as the basis for E2a-Pbx1-induced apoptosis. Rather, apoptosis resulted from expression of chimeric proteins containing N-terminal E2a fused to speci®c portions of Pbx1. The minimal portion of Pbx1 required for apoptosis consisted of its homeodomain and 12 anking amino acids. The latter constitute a conserved motif (named the Hox cooperativity motif or HCM) that also serves important roles for the transcriptional and transforming activities of E2a-Pbx1 (Chang et al., 1997) . As summarized in Table 2 , there is consistent absence of biological or transcriptional activity for minimal construct HD 232 ± 298 , which lacks the HCM, in contrast to the activity of HD 232 ± 310 which contains both the Pbx1 homeodomain and HCM. Based on mutational studies and molecular modeling (Chang et al., 1996) , the HCM is predicted to serve as a site of contact for heterologous DNA-binding partners such as class I Hox proteins. Given the requirement for the HCM, we conclude that E2a-Pbx1 must function as a transcriptional protein recognizing subordinate targets in the context of heterologous DNA-binding partners to eect apoptosis.
However, there are distinct dierences in the structural requirements for apoptosis versus transformation that provide additional insights into potential mechanisms that may underlie these biological properties of E2a-Pbx1. For instance, construct 1bDHD, lacking the Pbx1 homeodomain, was incapable of inducing apoptosis in contrast to its ability to transform ®broblasts. We have recently shown that the homeodomain-independent transforming properties of E2a-Pbx1 are critically dependent on the Pbx HCM (Chang et al., 1997) . Based on the ®ndings that subtle alterations of the Pbx HCM resulted in complete abrogation of transforming activity whereas the homeodomain was entirely dispensible, we concluded that heterologous protein-protein interactions mediated by the HCM are more important for transformation by E2a-Pbx1 than interactions with cognate Pbx DNA sites. However, a similar conclusion does not apply to E2a-Pbx1-induced apoptosis where Pbx-DNA interactions appear to be essential based on the inability of 1bDHD to induce apoptosis. These disparate ®ndings are likely to re¯ect the requirement for dierent DNAbinding partners to interact with E2a-Pbx1 to recognize subordinate target genes involved in apoptosis versus transformation. This suggestion is supported by results from construct D299 ± 308, containing a subtotal deletion of the HCM, which retains partial apoptotic potential but lacks transforming activity. In transcriptional and DNA-binding assays, D299 ± 308 shows variable activity dependent on which Hox proteins are provided as DNA-binding partners (Table 2 and Chang et al., 1997) . These dierences may be attributable to the variable structural requirements of dierent partners for HCM interactions which are unmasked by subtotal disruption of the HCM by the D299 ± 308 deletion.
A speci®c role for the Pbx moiety of E2a-Pbx1 in potentiating apoptosis is further demonstrated by the inability of E2a-Hlf to render Reh cells susceptible to apoptosis. E2a-Hlf, like E2a-Pbx1, is a chimeric transcriptional protein resulting from chromosomal translocations in B cell precursor leukemias, however E2a-Hlf contains a basic DNA-binding region and leucine zipper dimerization motif in contrast to the homeodomain contained by E2a-Pbx1. As a consequence, E2a-Hlf binds and activates transcription through DNA sites dierent from those recognized by E2a-Pbx1 or wild type E2a proteins (Hunger et al., 1994; Inaba et al., 1994) . Recent studies have shown that forced expression of E2a-Hlf prevents precursor B cells of the BaF3 cell line from undergoing apoptosis in response to IL3 withdrawal (Inaba et al., 1996) . These ®ndings raise the possibility that Hlf targets may equate with survival whereas Pbx targets may equate with apoptosis. However, we have not observed enhanced survival of lymphoid precursors expressing E2a-Hlf in vitro or in E2a-Hlf transgenic mice (Smith and Cleary, unpublished observation) suggesting that there are cell-type speci®c dierences in responses to chimeric Hlf as well as Pbx proteins. In the case of Pbx, this may in part re¯ect the spectrum of (Chang et al., 1995 (Chang et al., , 1997 Hunger et al., 1992; Inaba et al., 1994; Monica et al., 1994) . DNA-binding and transcriptional activation for Pbx chimeras were assessed on a PBX consensus site and for E2a-Hlf on an HLF consensus site (Hunger et al., 1992) . The DNA-binding and transcriptional properties of this construct vary depending on the binding site employed (Chang et al., 1997) endogenously expressed Hox proteins displaying dierent sequence speci®cities as cooperative DNAbinding complexes with E2a-Pbx1. The large repertoire of Hox proteins would allow for a range of potential functional outcomes.
Our studies show that E2a-Pbx1-induced apoptosis proceeds ultimately through a Bcl-2-regulated checkpoint and eventuates in PARP inactivation. These results strongly implicate the activation of a protease belonging to the CED3/ICE family of serine proteases, a group shown to contain several diverse members functionally able to cleave PARP whose proteolysis is a marker of apoptosis initiated by several stimuli (Lippke et al., 1996; Schlegel et al., 1996; Tewari et al., 1995) . We obtained no evidence that E2a-Pbx1-associated apoptosis was due to primary perturbations of this checkpoint due to alterations in the level of proteins such as Bcl-2, Mcl-1 or Bax, although down-regulation of Bcl-2 may be a late eect. Thus, the molecular events between transcriptional induction of E2a-Pbx1 subordinate genes and protease activation remain unknown. Potential genes that are regulated in part by contributions from Pbx-like proteins have been identi®ed through genetic analyses in Drosophila. The Drosophila homologue of Pbx1, extradenticle (exd), functions in parallel with homeotic selector genes abdominal A (abd-A), antennapedia (Antp), and ultrabithorax (Ubx) (Rauskolb et al., 1993) in regulating downstream genes essential in determining body segment identity (Rauskolb and Wieschaus, 1994) . Subordinate genes include wingless and decapentaplegic (dpp), which code for signaling molecules of the Wnt and TGFb families, respectively. Furthermore the human homologue of dpp was identi®ed as bone morphogenetic factor 4 (BMP-4) a signaling molecule shown to be required for interdigital apoptosis within the developing chick limb (Zou and Niswander, 1996) . Pbx has also been implicated as a cofactor with the non-Hox homeodomain protein STF-1 in the regulation of somatostatin gene expression (Peers et al., 1995) . These data are consistent with possible signaling molecules or cytokines as products of primary targets misregulated by E2a-Pbx1 in lymphoid precursors. We are currently investigating the potential role of TGFb family members and FAS ligand which are implicated in modulating lymphocyte survival in other settings.
Additional ®ndings further suggest that the mechanism by which E2a-Pbx1 renders cells susceptible to apoptosis may be fundamentally dierent than those employed by other nuclear oncoproteins. Most signi®cantly, E2a-Pbx1-induced apoptosis displays no requirement for tumor suppressor protein p53. Although p53 levels increased following zinc treatment of Reh cells, comparable increases were observed regardless of whether the cells expressed E2a-Pbx1. However, Reh cells were shown to be responsive to p53-mediated apoptosis induced by ionizing radiation (Smith and Cleary, unpublished observation). Apoptosis was also observed in HL-60 myeloid progenitor cells which do not express functional p53 protein. The lack of p53 requirement diers from apoptosis associated with forced expression of c-myc or adenoviral E1A proteins, whose eects on cell cycle progression generate signals that pass through a p53 checkpoint to eventuate in cell death (Debbas and White, 1993; Hermeking and Eick, 1994) . By comparison, E2a-Pbx1 induced apoptosis of hematolymphoid cells under normal growth conditions and did not obviously perturb the cycling activity of Reh cells (Smith and Cleary, unpublished observation) . Furthermore, constitutive expression of E2a-Pbx1 was incapable of sustaining continued cycling of Rat-1 cells under low serum conditions in which c-myc-expressing Rat-1 cells remained in cycle and underwent apoptosis. Taken together, these results suggest that the apoptotic process initiated by E2a-Pbx1 does not breach a p53 checkpoint and is unlikely to involve a re¯exive response to primary abnormalities of cell cycle control. Our ®ndings are consistent with the reported very low incidence of p53 mutations in t(1;19)-bearing human leukemias at diagnosis (Kawamura et al., 1995) .
The ability of E2a-Pbx1 to render lymphoid progenitors highly susceptible to apoptosis would appear to be inconsistent with its potential role in the leukemic transformation of the same cell type. However, our studies provide a plausible mechanism by which cells expressing E2a-Pbx1 may escape its apoptotic eects. Given that elevated levels of BCL2 suppress E2a-Pbx1-induced apoptosis in Reh cells, pre-B cells that have acquired t(1;19) translocations may be similarly protected by endogenously high levels of death suppressors (such as BCL2 or functionally analogous family members) relative to death accelerators such as BAX. Most t(1;19) leukemias display maturation arrest at the pre-B cell stage of differentiation with expression of cytoplasmic but not surface Ig mu chains. Pre-B cells typically express IL7 receptors and are exquisitely responsive to this cytokine which has potent survival eects. Therefore, concurrent physiologic survival signals may play an important role in E2a-Pbx1-associated leukemogenesis and potentially account for the association of the t(1;19) with a characteristic subset of human pediatric leukemias. The potential ability of synergistic interaction of Bcl-2 and E2a-Pbx1 to alter the growth of cells is currently being investigated in transgenic animal models. The availability of in vitro or animal models of pre-B cell transformation by E2a-Pbx1 as well as the identi®cation of bona ®de target genes would signi®cantly enhance eorts to dissect the apoptotic and oncogenic signaling cascades initiated by this chimeric transcription factor.
Materials and methods

Expression constructs and stable transfections
The full-length E2a-Pbx1a and E2a-Pbx1b cDNAs were cloned into the BamHI site of MRE-pNEO. The E2A-PBX1 mutant HD 232 ± 310 was made by partially digesting the E2a-Pbx1b cDNA with PvuII eliminating the region 3' of the fourth PvuII site and inserting a stop codon by PCR. The E2a-Pbx1 mutants D232 ± 430 was reported previously as D621 ± 819 (Monica et al., 1994) . A homeodomain deletion mutant of E2a-Pbx1b (1bDHD) was constructed by replacing the carboxy terminus of E2a-Pbx1a homeodomain mutant D621 ± 683 (Monica et al., 1994) with the carboxy terminal NcoI fragment of Pbx1b. The HD 232 ± 298 construct was produced by using PCR to add a stop codon immediately downstream from the homeodomain of the previously reported mutant D477 ± 620/708 ± 819 (Monica et al., 1994) . All mutant E2a-Pbx1 cDNAs and the E2a-Hlf cDNA (Hunger et al., 1992) were cloned into the BamHI site of MRE-pNEO by blunt-end ligation. E2a-Pbx1b and c-myc were blunt-end ligated into the EcoRI site of the retroviral vector COS-MSV/NEO which was used to prepare retroviral stocks employed for infection of Rat-1 ®broblasts. COS-MSV/NEO-E2a-Pbx1b or -c-myc were transiently transfected into the ectropic helper lines BOSC using the calcium phosphate technique. Viral supernatants were collected and added to logarithmically growing Rat-1 ®broblasts. Stable clones were selected in 500 mg/ml G418 sulfate and individual clones were isolated.
Reh cells were electroporated at a concentration of 4610 7 cells/ml using 20 mg linearized plasmid DNA. Cells were washed once in serum-free RPMI and incubated at room temperature in RPMI for 10 min prior to electroporation which was performed using a BioRad Gene Pulser with capacitance extender (Hercules, CA) at 400 V and 960 mFD at room temperature. Following electroporation, cells were incubated at room temperature in RPMI for 10 min then cultured for 48 h in RPMI 1640 containing 10% FCS (R-10). Stable transfectants were then selected in medium containing 500 mg/ml G418-sulfate for 2 weeks at which point single cell clones were isolated by either FACS sorting or limiting dilution into 96 well plates. Stable cell clones were maintained in R-10 containing 200 mg/ml G418-sulfate.
Expression and immunoblotting of protein
Stably transfected Reh clones were induced with zinc sulfate at a ®nal concentration of 100 mM in R-10. Induced cells were collected at speci®ed timepoints, washed in phosphate buered saline (PBS), lysed immediately in 16 sample buer (50 mM Tris-Cl (pH 6.8), 10% glycerol, 2% sodium dodecyl sulfate (SDS)) and boiled for 5 min. The lysates were sonicated and the OD 280 was determined. Ten micrograms of total cellular protein were subjected to SDS-polyacrylamide gel electrophoresis (PAGE) followed by Western blot analysis using an anti-E2a monoclonal antibody as previously described (Jacobs et al., 1993) . The homeodomain lacking construct (1bDHD) was detected using a Pbx1b-speci®c monoclonal antibody (YJ and MLC, unpublished) . Western blot analyses to assess various modulators of apoptosis were performed under similar conditions employing a rabbit antiserum speci®c for Bax (Santa Cruz Biotechnology), an anti-Bcl-2 monoclonal antibody (Dako Corp.), anti-Mcl-1 antisera (Dr John Reed, LaJolla Cancer Research Institute), an anti-p53 monoclonal antibody (PharMingen), and anti-PARP monoclonal antibody (Dr Guy Poirier, Centre Hospital, University Laval). Rat-1 ®broblasts were collected using cell scraping buer (150 mM NaCl, 40 mM Tris (pH 7.5), 1 mM EDTA) and lysed as described above. Western blot detection of E2a-Pbx1b production within Rat-1 ®broblasts was accomplished using an anti-E2a monoclonal antibody.
Assessment of apoptosis
Logarithmically growing, stably transfected cells containing full-length and mutant E2a-Pbx1 constructs were treated with 100 mM ZnSO 4 for 72 h at an initial concentration of 3610 5 cells/ml. Triplicate samplings were removed at 24 h intervals and scored for viable and apoptotic cells using a hemocytometer and a Nikon TMS inverted microscope equipped with a Ph 1 phase annular ring for contrast at 1506 magni®cation.
For isolation of chromosomal DNA and assessment of oligonucleosomal degradation, stably transfected Reh clones were treated with 100 mM ZnSO 4 for 36 h and washed once in PBS. Cells were disrupted in lysis buer (50 mM Tris (pH 7.5), 0.5% SDS, 100 mM NaCl, 2 mM EDTA (pH 8.0), 100 mg/ml proteinase K, 100 mg RNase A) and heated overnight at 608C. The lysate was brought to a ®nal concentration of 1.25 M potassium acetate and extracted once with phenol/chloroform. The DNA was precipitated with ethanol, resuspended in dH 2 O containing 100 mg RNase A and electrophoresed through 1.5% agarose-ethidium bromide gels in tris-acetate buer.
For bright ®eld microscopy, stably transfected Reh cells were treated with 100 mM ZnSO 4 for 36 h and photographed at 2006 magni®cation using a Nikon Microphot-FXA camera.
Cell cycle analysis
FACS analysis to determine DNA content of RAT-1 cells was performed by lysing 72 h serum-starved or log-phase cells in DNA cell cycle buer (PBS containing 100 mg/ml Rnase A, 10 mg/ml propidium iodide, and 1% and incubating overnight at 48C. Nuclei were analysed on a Becton-Dickinson FACS-Calibur and DNA content was calculated using ModFit software (Becton Dickinson, San Jose, CA). To determine the percentage of cells in S phase, Rat-1/E2a-Pbx1b, c-myc and vector-only cells were incubated in DMEM-0.1% FCS (D-0.1) for 48 h then metabolically labeled in D-0.1 containing 100 mM bromodeoxyuridine (BrdU) for 2 h. Adherent cells were then washed and ®xed in 70% ethanol at 7208C for 10 min and treated with 2N HCL/0.8% Tween-20. Samples were neutralized in 100 mM NaB 4 O 7 -10H 2 O for 10 min and stained with a FITC-conjugated monoclonal antibody directed against BrdU (Becton Dickinson). The percentage of cells traversing S phase was determined microscopically by quantitating FITC-positive cells as a fraction of total cells stained with Hoechst nuclear counterstain.
